Brent B. Secrest - Feb 16, 2025 Form 4 Insider Report for ENTERPRISE PRODUCTS PARTNERS L.P. (EPD)

Role
EVP & CHIEF COMMERCIAL OFFICER
Signature
/s/Jennifer W. Dickson, Attorney-in-Fact on Behalf of Brent B. Secrest
Stock symbol
EPD
Transactions as of
Feb 16, 2025
Transactions value $
-$1,250,641
Form type
4
Date filed
2/19/2025, 05:55 PM
Previous filing
Feb 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EPD Common Units Representing Limited Partnership Interests Options Exercise +23.8K +7.13% 357K Feb 16, 2025 Direct F1
transaction EPD Common Units Representing Limited Partnership Interests Tax liability -$315K -9.35K -2.62% $33.72 348K Feb 16, 2025 Direct
transaction EPD Common Units Representing Limited Partnership Interests Options Exercise +23.8K +6.83% 371K Feb 16, 2025 Direct F1
transaction EPD Common Units Representing Limited Partnership Interests Tax liability -$315K -9.35K -2.52% $33.72 362K Feb 16, 2025 Direct
transaction EPD Common Units Representing Limited Partnership Interests Options Exercise +25K +6.91% 387K Feb 16, 2025 Direct F1
transaction EPD Common Units Representing Limited Partnership Interests Tax liability -$332K -9.84K -2.54% $33.72 377K Feb 16, 2025 Direct
transaction EPD Common Units Representing Limited Partnership Interests Options Exercise +21.8K +5.77% 399K Feb 16, 2025 Direct F1
transaction EPD Common Units Representing Limited Partnership Interests Tax liability -$289K -8.56K -2.15% $33.72 390K Feb 16, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EPD Phantom Units Options Exercise $0 -23.8K -100% $0.00 0 Feb 16, 2025 Common Units 23.8K Direct F1, F2
transaction EPD Phantom Units Options Exercise $0 -23.8K -50% $0.00 23.8K Feb 16, 2025 Common Units 23.8K Direct F1, F3
transaction EPD Phantom Units Options Exercise $0 -25K -33.33% $0.00 50K Feb 16, 2025 Common Units 25K Direct F1, F4
transaction EPD Phantom Units Options Exercise $0 -21.8K -25% $0.00 65.3K Feb 16, 2025 Common Units 21.8K Direct F1, F5
holding EPD Phantom Units 73.5K Feb 16, 2025 Common Units 73.5K Direct F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each phantom unit is the economic equivalent of one EPD common unit.
F2 These phantom units vested in one remaining annual installment on February 16, 2025. The remaining annual installment expired upon vesting and settlement thereof in exchange for an equal number of EPD common units.
F3 These phantom units vest in two remaining equal annual installments beginning on February 16, 2025. Each remaining annual installment will expire upon vesting and settlement thereof in exchange for an equal number of EPD common units.
F4 These phantom units vest in three remaining equal annual installments beginning on February 16, 2025. Each remaining annual installment will expire upon vesting and settlement thereof in exchange for an equal number of EPD common units.
F5 These phantom units vest in four equal annual installments beginning on February 16, 2025. Each annual installment will expire upon vesting and settlement thereof in exchange for an equal number of EPD common units.
F6 These phantom units vest in four equal annual installments beginning on February 16, 2026. Each annual installment will expire upon vesting and settlement thereof in exchange for an equal number of EPD common units.
F7 The power of attorney under which this form was signed is on file with the Commission.

Remarks:

Transaction Code M - Exercise or conversion of derivative security exempted pursuant to Rule 16b-3; Transaction Code F - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3